Pharma – partners of NHS choice?
October 19, 2005The government sees choice as a major driver for promoting quality, responsiveness, efficiency and equity in public services. Choice in …
Merck to co-develop novel prostate cancer candidate
October 18, 2005Research and Development
Merck is to develop a new monoclonal antibody which has shown promise in treating prostate cancer.The US company has signed …
Exubera recommended by European regulator
October 18, 2005Sales and Marketing
Exubera, the first ever inhaled insulin product is set for approval in Europe following a key regulatory recommendation.The positive opinion …
Winning CROs look east for expansion
October 18, 2005Research and Development
The new onus on outsourcing has seen CROs reap the benefits of an industry striving to cut resource investment while …
Pharma increases vaccine production as bird flu hits Europe
October 14, 2005Manufacturing and Production
Pharmaceutical companies are being urged to step up vaccine production as the strain of bird flu that killed 59 people …
Pfizer wins UK Lipitor court battle
October 14, 2005Sales and Marketing
Pfizer has won an important legal battle to maintain its UK patent on best-selling cholesterol drug Lipitor.The UK High Court …
Sanofi-Aventis launch new short-acting insulin competitor Apidra
October 13, 2005Sales and Marketing
Apidra, a new short-acting insulin analogue, has been launched in the UK by Sanofi-Aventis.Short-acting analogues have a faster onset of …
EMEA reforms to speed drug approval
October 13, 2005Sales and Marketing
Europe's medicines regulator is looking to communicate more effectively with pharma companies as part of a drive to accelerate drug …
Merck looks to rebuild reputation one year on from Vioxx
October 13, 2005Sales and Marketing
Merck looks set to launch a new public relations campaign across Europe in an attempt to repair damage done to …
Unions vote against NHS ‘privatisation’
October 13, 2005The government lost the vote at its party conference on expanding the role of the private sector in the NHS.A …
VNU shareholders rebel over IMS bid
October 13, 2005Sales and Marketing
A significant minority of shareholders in VNU are against its planned $7 billion acquisition of pharmaceutical information company IMS Health.The …
Reducing POM to P headaches
October 12, 2005Sales and Marketing
Following an eight-week period of public consultation, the Committee on Safety of Medicines is to shortly advise health ministers about …
Creative Lynx to work on Novartis transplantation brands
October 12, 2005Medical Communications
Novartis has awarded advertising accounts for its ophthalmology and transplantation portfolios to Manchester-based advertising agency Creative Lynx.The pharma company held …
GPs need pharma expertise
October 5, 2005GPs are calling out for pharmaceutical companies to provide them with management skills as they take on a new role …
Resolute selected for IBD campaign
October 3, 2005Medical Communications
Procter & Gamble has chosen Resolute Communications to conduct a combined PR and medical education programme for its inflammatory bowel …
Pharma cast as ‘bad guys’ in Hollywood blockbuster
September 30, 2005Sales and Marketing
A new Hollywood thriller featuring the pharmaceutical industry as the 'bad guys' is to hit UK screens next week.The Constant …
Genzyme opens first European research centre in Cambridge
September 30, 2005Research and Development
Genzyme, one of the most successful US biotech companies, has opened its first European research centre in Cambridge, UK – …
Davis to leave Takeda UK
September 30, 2005Sales and Marketing
Andy Davis, the high-profile managing director of Takeda UK is to leave the company.Davis is best known for overseeing a …
New leader for FDA in turmoil
September 30, 2005Sales and Marketing
Andrew von Eschenbach has been appointed the new acting head of the FDA after the surprise resignation of Lester Crawford.Crawford …
NICE seeks urgent fix for slow appraisals
September 29, 2005Sales and Marketing
Patients waiting for access to new, more effective medicines could be prescribed them earlier if new proposals are adopted.NICE, the …
Latest content
FibroFind appoints Lee Borthwick as CEO
